Skip to content

Clinical trials

Phase 3 Breast Neoplasms trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 3 Country / region: New Zealand Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20034
20043
20052
20062
20073
20081
20094
20101
20111
20121
20141
20172
20181
20191
20201
20212
20221
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Active, not recruiting9
Recruiting5
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche9
ETOP IBCSG Partners Foundation7
Novartis Pharmaceuticals4
Sanofi4
Eli Lilly and Company3
Merck Sharp & Dohme LLC3
AstraZeneca2
GlaxoSmithKline2
Pfizer2
Alliance Foundation Trials, LLC.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms43
Neoplasm Metastasis2
Triple Negative Breast Neoplasms2
Bone Diseases, Metabolic1
Breast Diseases1
Fatigue1
Infertility1
Neoplasms1
Neoplasms by Site1
Osteoporosis1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.